Left Ventricular Remodeling Leads to Heart Failure in Mice with Cardiac-specific Overexpression of VEGF-B: Echocardiography and Magnetic Resonance Imaging Study

Overview

Journal Physiol Rep

Specialty Physiology

Date 2017 Mar 30

PMID 28351964

Citations 10

Authors

Line Lottonen-Raikaslehto

Riina Rissanen

Erika Gurzeler

Mari Merentie

Jenni Huusko

Jurgen E Schneider

Timo Liimatainen

Seppo Yla-Herttuala

Affiliations

Soon will be listed here.

Abstract

Cardiac-specific overexpression of vascular endothelial growth factor (VEGF)-B is known to induce left ventricular hypertrophy due to altered lipid metabolism, in which ceramides accumulate to the heart and cause mitochondrial damage. The aim of this study was to evaluate and compare different imaging methods to find the most sensitive way to diagnose at early stage the progressive left ventricular remodeling leading to heart failure. Echocardiography and cardiovascular magnetic resonance imaging were compared for imaging the hearts of transgenic mice with cardiac-specific overexpression of VEGF-B and wild-type mice from 5 to 14 months of age at several time points. Disease progression was verified by molecular biology methods and histology. We showed that left ventricular remodeling is already ongoing at the age of 5 months in transgenic mice leading to heart failure by the age of 14 months. Measurements from echocardiography and cardiovascular magnetic resonance imaging revealed similar changes in cardiac structure and function in the transgenic mice. Changes in histology, gene expressions, and electrocardiography supported the progression of left ventricular hypertrophy. Longitudinal relaxation time in rotating frame (T ) in cardiovascular magnetic resonance imaging could be suitable for detecting severe fibrosis in the heart. We conclude that cardiac-specific overexpression of VEGF-B leads to left ventricular remodeling at early age and is a suitable model to study heart failure development with different imaging methods.

Citing Articles

PGRMC2 is a pressure-volume regulator critical for myocardial responses to stress in mice.

Amirrad F, La V, Ohadi S, Albotaif M, Webster S, Pru J Nat Commun. 2025; 16(1):2422.

PMID: 40069180 PMC: 11897200. DOI: 10.1038/s41467-025-57707-8.

Contribution of VEGF-B-Induced Endocardial Endothelial Cell Lineage in Physiological Versus Pathological Cardiac Hypertrophy.

Sultan I, Ramste M, Peletier P, Hemanthakumar K, Ramanujam D, Tirronen A Circ Res. 2024; 134(11):1465-1482.

PMID: 38655691 PMC: 11542978. DOI: 10.1161/CIRCRESAHA.123.324136.

Comprehensive bioinformatics analysis identifies LAPTM5 as a potential blood biomarker for hypertensive patients with left ventricular hypertrophy.

Li T, Wang W, Gan W, Lv S, Zeng Z, Hou Y Aging (Albany NY). 2022; 14(3):1508-1528.

PMID: 35157609 PMC: 8876903. DOI: 10.18632/aging.203894.

Getting to the heart of the sphingolipid riddle.

Law B, Hancock W, Cowart L Curr Opin Physiol. 2020; 1:111-122.

PMID: 33195889 PMC: 7665081. DOI: 10.1016/j.cophys.2017.10.002.

Luhong Formula Has a Cardioprotective Effect on Left Ventricular Remodeling in Pressure-Overloaded Rats.

Liu Q, Qu H, Zhou H, Rong J, Yang T, Xu J Evid Based Complement Alternat Med. 2020; 2020:4095967.

PMID: 32565857 PMC: 7277070. DOI: 10.1155/2020/4095967.

References

Speerschneider T, Thomsen M . Physiology and analysis of the electrocardiographic T wave in mice. Acta Physiol (Oxf). 2013; 209(4):262-71. DOI: 10.1111/apha.12172. View

Schelbert E, Piehler K, Zareba K, Moon J, Ugander M, Messroghli D . Myocardial Fibrosis Quantified by Extracellular Volume Is Associated With Subsequent Hospitalization for Heart Failure, Death, or Both Across the Spectrum of Ejection Fraction and Heart Failure Stage. J Am Heart Assoc. 2015; 4(12). PMC: 4845263. DOI: 10.1161/JAHA.115.002613. View

Arendt Jensen J . Medical ultrasound imaging. Prog Biophys Mol Biol. 2006; 93(1-3):153-65. DOI: 10.1016/j.pbiomolbio.2006.07.025. View

Oikarinen L, Nieminen M, Viitasalo M, Toivonen L, Jern S, Dahlof B . QRS duration and QT interval predict mortality in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension. 2004; 43(5):1029-34. DOI: 10.1161/01.HYP.0000125230.46080.c6. View

Boulaksil M, Winckels S, Engelen M, Stein M, van Veen T, Jansen J . Heterogeneous Connexin43 distribution in heart failure is associated with dispersed conduction and enhanced susceptibility to ventricular arrhythmias. Eur J Heart Fail. 2010; 12(9):913-21. DOI: 10.1093/eurjhf/hfq092. View

Huusko J, Merentie M, Dijkstra M, Ryhanen M, Karvinen H, Rissanen T . The effects of VEGF-R1 and VEGF-R2 ligands on angiogenic responses and left ventricular function in mice. Cardiovasc Res. 2009; 86(1):122-30. DOI: 10.1093/cvr/cvp382. View

Go A, Mozaffarian D, Roger V, Benjamin E, Berry J, Blaha M . Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation. 2013; 129(3):e28-e292. PMC: 5408159. DOI: 10.1161/01.cir.0000441139.02102.80. View

Mudd J, Kass D . Tackling heart failure in the twenty-first century. Nature. 2008; 451(7181):919-28. DOI: 10.1038/nature06798. View

Amundsen B, Ericsson M, Seland J, Pavlin T, Ellingsen O, Brekken C . A comparison of retrospectively self-gated magnetic resonance imaging and high-frequency echocardiography for characterization of left ventricular function in mice. Lab Anim. 2010; 45(1):31-7. DOI: 10.1258/la.2010.010094. View

10.

Schneider J, Wiesmann F, Lygate C, Neubauer S . How to perform an accurate assessment of cardiac function in mice using high-resolution magnetic resonance imaging. J Cardiovasc Magn Reson. 2006; 8(5):693-701. DOI: 10.1080/10976640600723664. View

11.

Abdel-Aty H, Zagrosek A, Schulz-Menger J, Taylor A, Messroghli D, Kumar A . Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction. Circulation. 2004; 109(20):2411-6. DOI: 10.1161/01.CIR.0000127428.10985.C6. View

12.

Lottonen-Raikaslehto L, Rissanen R, Gurzeler E, Merentie M, Huusko J, Schneider J . Left ventricular remodeling leads to heart failure in mice with cardiac-specific overexpression of VEGF-B: echocardiography and magnetic resonance imaging study. Physiol Rep. 2017; 5(6). PMC: 5371547. DOI: 10.14814/phy2.13096. View

13.

Caudron J, Mulder P, Nicol L, Richard V, Thuillez C, Dacher J . MR relaxometry and perfusion of the myocardium in spontaneously hypertensive rat: correlation with histopathology and effect of anti-hypertensive therapy. Eur Radiol. 2013; 23(7):1871-81. DOI: 10.1007/s00330-013-2801-6. View

14.

Kaese S, Verheule S . Cardiac electrophysiology in mice: a matter of size. Front Physiol. 2012; 3:345. PMC: 3433738. DOI: 10.3389/fphys.2012.00345. View

15.

Mitchell G, Jeron A, Koren G . Measurement of heart rate and Q-T interval in the conscious mouse. Am J Physiol. 1998; 274(3):H747-51. DOI: 10.1152/ajpheart.1998.274.3.H747. View

16.

Farmakis D, Stafylas P, Giamouzis G, Maniadakis N, Parissis J . The medical and socioeconomic burden of heart failure: A comparative delineation with cancer. Int J Cardiol. 2015; 203:279-81. DOI: 10.1016/j.ijcard.2015.10.172. View

17.

Diez J, Querejeta R, Lopez B, Gonzalez A, Larman M, Martinez Ubago J . Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation. 2002; 105(21):2512-7. DOI: 10.1161/01.cir.0000017264.66561.3d. View

18.

Kivela R, Bry M, Robciuc M, Rasanen M, Taavitsainen M, Silvola J . VEGF-B-induced vascular growth leads to metabolic reprogramming and ischemia resistance in the heart. EMBO Mol Med. 2014; 6(3):307-21. PMC: 3958306. DOI: 10.1002/emmm.201303147. View

19.

Merentie M, Lipponen J, Hedman M, Hedman A, Hartikainen J, Huusko J . Mouse ECG findings in aging, with conduction system affecting drugs and in cardiac pathologies: Development and validation of ECG analysis algorithm in mice. Physiol Rep. 2015; 3(12). PMC: 4760442. DOI: 10.14814/phy2.12639. View

20.

Rose-Hellekant T, Gilchrist K, Sandgren E . Strain background alters mammary gland lesion phenotype in transforming growth factor-alpha transgenic mice. Am J Pathol. 2002; 161(4):1439-47. PMC: 1867309. DOI: 10.1016/s0002-9440(10)64419-7. View